Podcast: Using Analytics, Precision Medicine to Improve Preterm Infant Outcomes

Samara Rosenfeld

Tracy Warren, CEO and co-founder of Astarte Medical, discusses leveraging predictive analytics to measure the gut microbiome in preterm infants.

Investigators are leveraging precision medicine to tailor treatment for an individual patient and improve outcomes.

Astarte Medical is a precision medicine company that uses software and predictive analytics to improve premature infant outcomes. Tracey Warren, Astarte Medical’s CEO and co-founder, is featured on this week’s episode of Data Book.

Warren discusses how the company was conceived, the importance of focusing on the gut microbiome of preterm infants, the ways in which Astarte Medical uses predictive analytics and precision medicine and the direction she sees the company going in the future.

Connect with us on Twitter and let us know what you want to hear on Data Book this season.

Get the best insights in digital health directly to your inbox.

Binge More Data Book

How FDA Is Navigating the Digital Transformation

Playing a Medical Video Game for CME Credit

A Closer Look at Pear Therapeutics